Semaglutide lowers them and helps your body control sugar
1) Limited sample sizes and study design: There is a lack of large, well-designed randomized controlled trials
It may be a fit for patients who: Have appetite regulation challenges Have signs of insulin resistance Have struggled with repeated weight loss attempts Need stronger metabolic support Have not responded as expected to other approaches Have a medical history that supports tirzepatide use Can tolerate the medication appropriately Tirzepatide may be appealing because of its dual-hormone mechanism, but stronger does not always mean better for every person
This is actually a benefit up to a point (more oxygen-carrying capacity), but hematocrit above 52-54% increases blood viscosity and blood clot risk
For some practices, compounded GLP-1 may be an option during shortages
C., Growth Hormone & IGF Research Bloodwork Recommendations Post-Cycle After any peptide or hormone protocol, evaluate: Fasting glucose and insulin levels Serum IGF-1 Lipid profile ALT/AST (liver enzymes) Testosterone and LH/FSH (if androgens were used) This allows for targeted recovery interventions and long-term metabolic monitoring